Monthly Archives: April 2021

Longer term outcomes; what should we measure? part 1.

Posted on 22 April 2021 by Keith Barrington

Many important trials include follow-up to about 2 years in order to ascertain longer-term effects. Such as this one: Adams-Chapman I, et al. Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial. J Perinatol. 2021. Ira Adams-Chapman was … Continue reading →

Posted in Neonatal Research | Tagged , , | 2 Comments

More thoughts about what to de-adopt

Posted on 20 April 2021 by Keith Barrington

My post about de-adopting certain investigations or procedures in the NICU got a lot of suggestions and responses. Here are a few, either from the comments section or from Twitter. We should de-adopt the following: Dopamine. This is a suggestion … Continue reading →

Posted in Neonatal Research | Leave a comment

Medication use in babies with bronchopulmonary dysplasia

Posted on 19 April 2021 by Keith Barrington

A few recent studies have noted the marked variability between sites in the use of medications in preterm infants with BPD. Nelin TD, et al. The association between diuretic class exposures and enteral electrolyte use in infants developing grade 2 … Continue reading →

Posted in Neonatal Research | 2 Comments

The ACOG patient information page; what should it say about 22, 23, 24 weekers?

Posted on 16 April 2021 by Keith Barrington

I mentioned not so long ago that the web page of the US Obstetricians professional association has information for prospective parents of babies of less than 25 weeks gestation that is… questionable. They state, for example, the following : Medical … Continue reading →

Posted in Neonatal Research | Tagged , | 7 Comments

What should we de-adopt in Neonatology?

Posted on 15 April 2021 by Keith Barrington

When practices become ingrained in practice it can be very difficult to change them, even when new evidence becomes available, or a review of existing evidence points out that the practice is worthless. An editorial towards the end of last … Continue reading →

Posted in Neonatal Research | 8 Comments

Long term outcomes; the 2 year Bayley tells us very little

Posted on 14 April 2021 by Keith Barrington

The Bayley Scales of Infants Development were created to screen babies for developmental delay, and can be used as one way of identifying children with potential problems, and then determining whether they might benefit from intervention. Unfortunately they have become … Continue reading →

Posted in Neonatal Research | Leave a comment

Coagulopathy and intraventricular haemorrhage

Posted on 13 April 2021 by Keith Barrington

Intraventricular haemorrhages continue to be a source of concern to families of very preterm babies, and to all of us; severe hemorrhages are associated with poorer outcomes, especially bilateral extensive periventricular haemorrhagic infarction. This is one of my occasional series … Continue reading →

Posted in Neonatal Research | 7 Comments

Back to blogging

Posted on 12 April 2021 by Keith Barrington

I have been unable for various reasons to blog for a while, but getting back in the saddle is a good feeling, and I plan to try and blog at least once a week. There have been a few blog … Continue reading →

Posted in Neonatal Research | 5 Comments

The HIP trial, treating hypotension in the extremely preterm infant.

Posted on 12 April 2021 by Keith Barrington

I guess the HIP trial should be about screening for congenital dislocation, but in reality, it stands for Hypotension In Preterm infants. The long road to the unsatisfactory conclusion of the trial started more than 10 years ago, in discussions … Continue reading →

Posted in Neonatal Research | 5 Comments